Cardiology Department, Munich University Clinic, Germany.
Radiology Department, Munich University Clinic, Germany.
Clin Radiol. 2014 Oct;69(10):1034-8. doi: 10.1016/j.crad.2014.05.106. Epub 2014 Jul 10.
To identify independent predictors of contrast medium-induced acute kidney injury (CI-AKI) after enhanced multidetector-row computed tomography (MDCT) prior to transcatheter aortic valve implantation (TAVI) in high-risk patients.
The present single-centre study analysed retrospectively 361 patients who were assessed using MDCT prior to TAVI. CI-AKI was defined as an increase in serum creatinine (SCr) of ≥ 25% or ≥ 0.5 mg/dl in at least one sample over baseline (24 h before MDCT) and at 24, 48, and 72 h after MDCT.
A total of 38 patients (10.5%) experienced CI-AKI. As compared to patients without CI-AKI, they presented more frequently with estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2), (81.6% versus 64.4%, p = 0.045) and tended to receive higher volumes of iodinated contrast media (ICM; 55.3% versus 39%, p = 0.057). There was a significant interaction between baseline eGFR and the amount of intravenous ICM administered (pfor interaction = <0.001) identifying the amount of ICM >90 ml as independent predictive factor of CI-AKI only in patients with baseline eGFR <60 ml/min/1.73m(2) (OR 2.615; 95% CI: 1.21-5.64).
One in ten elderly patients with aortic stenosis undergoing MDCT to plan a TAVI procedure experienced CI-AKI after intravenous ICM injection. Intravenous administration of <90 ml of ICM reduces this risk in patients with or without pre-existing impaired renal function. However, in the majority of patients renal function recovers before the TAVI procedure.
在经导管主动脉瓣植入术(TAVI)前,通过多排螺旋 CT(MDCT)增强扫描评估高危患者,以确定对比剂诱导的急性肾损伤(CI-AKI)的独立预测因子。
本单中心回顾性研究分析了 361 例在 TAVI 前接受 MDCT 评估的患者。CI-AKI 的定义为血清肌酐(SCr)在至少一个样本中较基线(MDCT 前 24 小时)增加≥25%或≥0.5mg/dl,且在 MDCT 后 24、48 和 72 小时。
共有 38 例(10.5%)患者发生 CI-AKI。与无 CI-AKI 的患者相比,他们的估算肾小球滤过率(eGFR)<60ml/min/1.73m(2)更为常见(81.6%对 64.4%,p=0.045),且倾向于接受更高剂量的碘造影剂(ICM)(55.3%对 39%,p=0.057)。基础 eGFR 和静脉内 ICM 用量之间存在显著的交互作用(pfor 交互=<0.001),仅在基础 eGFR<60ml/min/1.73m(2)的患者中,静脉 ICM 用量>90ml 是 CI-AKI 的独立预测因子(OR 2.615;95%CI:1.21-5.64)。
在计划行 TAVI 术的主动脉瓣狭窄老年患者中,十分之一的患者在接受 MDCT 增强扫描后发生了 CI-AKI。静脉内给予<90ml 的 ICM 可降低有或无预先存在的肾功能损害患者的这种风险。然而,在大多数患者中,肾功能在 TAVI 术前恢复。